Black Rock Inc. Supernus Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,362,356 shares of SUPN stock, worth $281 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,362,356

Previous 10,382,770 0.2%

Holding current value

$281 Million

Previous $300 Million 17.63%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$27.11 - $35.17 $553,423 - $717,960	-20,414 Reduced 0.2%	10,362,356 $353 Million
Q4 2023 Feb 13, 2024	BUY	$22.72 - $29.68 $4.61 Million - $6.02 Million	202,865 Added 1.99%	10,382,770 $300 Million
Q3 2023 Nov 13, 2023	BUY	$27.57 - $32.91 $6.05 Million - $7.22 Million	219,482 Added 2.2%	10,179,905 $281 Million
Q2 2023 Aug 11, 2023	BUY	$29.91 - $38.73 $13.8 Million - $17.9 Million	461,053 Added 4.85%	9,960,423 $299 Million
Q1 2023 May 12, 2023	SELL	$34.93 - $42.03 $3.69 Million - $4.44 Million	-105,522 Reduced 1.1%	9,499,370 $344 Million

Q4 2022 Feb 13, 2023	BUY	$31.09 - $37.88 $12.1 Million - $14.7 Million	388,318 Added 4.21%	9,604,892 $343 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $12.1 Million - $14.9 Million	420,429 Added 4.78%	9,216,574 $312 Million
Q2 2022 Aug 12, 2022	SELL	$25.33 - $34.25 $2.37 Million - $3.2 Million	-93,430 Reduced 1.05%	8,796,145 $254 Million
Q1 2022 May 12, 2022	BUY	$28.51 - $32.9 $12.5 Million - $14.4 Million	438,553 Added 5.19%	8,889,575 $287 Million
Q4 2021 Feb 10, 2022	SELL	$26.37 - $34.22 $10.8 Million - $14 Million	-407,715 Reduced 4.6%	8,451,022 $246 Million
Q3 2021 Nov 09, 2021	SELL	$23.54 - $31.39 $313,435 - $417,957	-13,315 Reduced 0.15%	8,858,737 $236 Million
Q2 2021 Aug 11, 2021	BUY	$26.72 - $33.19 $237 Million - $294 Million	8,872,052 New	8,872,052 $273 Million

Others Institutions Holding SUPN

# of Institutions

260

Shares Held

57.3M

Call Options Held

84.1K

Put Options Held

61.2K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.45B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account